Latest filing published 23 Mar 2022 for Voyager Therapeutics, Inc., €20k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Julie Burek: trading record in brief
All filings by Julie Burek on record concern Voyager Therapeutics, Inc., in the capacity of finance chief. Between 26 November 2021 and 21 March 2022, the trades on record add up to 9 filings.
Every open-market trade on record is a sale: 6 sales worth €32k. Besides market trades, the filings include 3 share grants. So far in 2022, the count stands at no purchases and 6 sales.
The record was last updated on 23 March 2022 with an open-market sale (€244) in Voyager Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Julie Burek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,618 shares@ US$8.2966.9% of flowCommon StockSEC:0001104659-22-037151:0
- 789 shares@ US$3.558.4% of flowCommon StockSEC:0001104659-22-025669:0
- 361 shares@ US$3.363.6% of flowCommon StockSEC:0001104659-22-023833:0
- 10,000 shares0Common StockSEC:0001104659-22-005023:0
- 3,063 shares@ US$2.3021.2% of flowCommon StockSEC:0001104659-22-004515:0
- 13,500 shares0Common StockSEC:0001104659-21-144995:0
6 of 6 declarations
